Suchergebnisse - "Arkania, Ekaterine"

PubPharm (4)

1

A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004)

enthalten in: Cancer cell | 2024

von Zhou, C. | Hu, Y. | Arkania, E. | +24

CommentIn: Cancer Cell. 2024 Feb 12;42(2):172-174. - PMID 38350419

2

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer : The ASTRUM-005 Randomized Clinical Trial

enthalten in: JAMA | 2022

von Cheng, Y. | Han, L. | Wu, L. | +106

CommentIn: JAMA. 2022 Sep 27;328(12):1205-1207. - PMID 36166047

3

Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy

enthalten in: The oncologist | 2020

von Schwartzberg, L. | Navari, R. | Clark-Snow, R. | +9

4

Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy‐Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy

enthalten in: The oncologist | 2020

von Schwartzberg, L. | Navari, R. | Clark‐Snow, R. | +9

1
[1]